Comparison of cautery and laser in polycystic ovary syndrome patients
Not Applicable
- Conditions
- Poly cystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT2017091636164N1
- Lead Sponsor
- Dr Dabirashrafi Fertility Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Inclusion criteria were as follow:
Having 2 criteria from 3 of Rotterdam criteria for diagnosis of PCOD; oligomenorrhea or amenorrhea; Clinical or biochemical evidence of hyperandrogenism; Sonographic findings of polycyctic ovary ( more than 10 primary follicle in each ovary)
Exclusion criteria: Positive history of previous pelvic surgery; Evidence of pelvic adhesion; Evidence of pelvic organ abnormality; Pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum Anti Mullerian hormone levels. Timepoint: Three and 6 months after operation. Method of measurement: Serum AMH levels by Gen II ELIZA.;Serum Inhibin B levels. Timepoint: Three and 6 months after operation. Method of measurement: Serum Inhibin B levels by ELIZA Gen II.
- Secondary Outcome Measures
Name Time Method Serum FSH level. Timepoint: Three and 6 months after operation. Method of measurement: Solid-phase sandwich enzyme- immunoassay.;Serum LH level. Timepoint: Three and 6 months after operation. Method of measurement: Solid-phase sandwich enzyme- immunoassay.;Serum total testestrone level. Timepoint: Three and 6 months after operation. Method of measurement: ELIZA.